Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma

Clinical Immunology - Tập 258 - Trang 109802 - 2024
Xisong Liang1,2, Zeyu Wang1,2, Ziyu Dai1,2, Jian Liu3, Hao Zhang1,2, Jie Wen1,2, Nan Zhang4, Jian Zhang5, Peng Luo5, Zaoqu Liu6, Zhixiong Liu1,2, Quan Cheng1,2,7
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, PR China
2National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Central South University, Changsha 410008, Hunan, PR China
3Experiment Center of Medical Innovation, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, Hunan, China
4College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, Hubei, PR China
5Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, Guangdong, PR China
6Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, PR China
7Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China

Tài liệu tham khảo

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol., 114, 97, 10.1007/s00401-007-0243-4 Molinaro, 2019, Genetic and molecular epidemiology of adult diffuse glioma, nature reviews, Neurology, 15, 405 Louis, 2016, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol., 131, 803, 10.1007/s00401-016-1545-1 Louis, 2021, The 2021 WHO classification of tumors of the central nervous system: a summary, Neuro-oncology, 23, 1231, 10.1093/neuonc/noab106 Malta, 2018, Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications, Neuro-oncology, 20, 608, 10.1093/neuonc/nox183 Verhaak, 2010, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, 17, 98, 10.1016/j.ccr.2009.12.020 Yang, 2022, Glioma targeted therapy: insight into future of molecular approaches, Mol. Cancer, 21, 39, 10.1186/s12943-022-01513-z Hayes, 2020, Oxidative stress in cancer, Cancer Cell, 38, 167, 10.1016/j.ccell.2020.06.001 Olivier, 2020, Drug resistance in glioblastoma: the two faces of oxidative stress, Front. Mol. Biosci., 7 Cheng, 2020, Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress, Cell Metab., 32, 229, 10.1016/j.cmet.2020.06.002 Cholia, 2018, Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes, Metab. Brain Dis., 33, 1307, 10.1007/s11011-018-0233-3 Dong, 2022, Emerging role of natural products in cancer immunotherapy, Acta Pharm. Sin. B, 12, 1163, 10.1016/j.apsb.2021.08.020 Xuan, 2021, Context-dependent glioblastoma-macrophage/microglia Symbiosis and associated mechanisms, Trends Immunol., 42, 280, 10.1016/j.it.2021.02.004 Wang, 2022, Metabolism and polarization regulation of macrophages in the tumor microenvironment, Cancer Lett., 543, 10.1016/j.canlet.2022.215766 Kuo, 2020, Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis, Cancer Lett., 474, 138, 10.1016/j.canlet.2020.01.019 Sun, 2020, Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages, Aging, 12, 1114, 10.18632/aging.102648 Zhao, 2021, Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients, Genom. Proteom. Bioinform., 19, 1, 10.1016/j.gpb.2020.10.005 Gusev, 2018, The REMBRANDT study, a large collection of genomic data from brain cancer patients, Sci. Data, 5, 180158, 10.1038/sdata.2018.158 Joo, 2013, Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ, Cell reports, 3, 260, 10.1016/j.celrep.2012.12.013 Joy, 2014, AKT pathway genes define 5 prognostic subgroups in glioblastoma, PloS one, 9, 10.1371/journal.pone.0100827 Kawaguchi, 2013, Gene expression signature-based prognostic risk score in patients with glioblastoma, Cancer sci., 104, 1205, 10.1111/cas.12214 Murat, 2008, Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma, J. Clin. Oncol. : official Am. J. Clin. Oncol., 26, 3015, 10.1200/JCO.2007.15.7164 Yu, 2016, Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme, Oncotarget, 7, 14161, 10.18632/oncotarget.7416 Feng, 2017, Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme, Sci. Rep., 7, 6968, 10.1038/s41598-017-05538-z Zhang, 2020, ComBat-seq: batch effect adjustment for RNA-seq count data, NAR genomics and bioinformatics, 2, lqaa078 Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature genetics, 34, 267, 10.1038/ng1180 Hänzelmann, 2013, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinform., 14, 7, 10.1186/1471-2105-14-7 Yoshihara, 2013, Inferring tumour purity and stromal and immune cell admixture from expression data, Nat. Commun., 4, 2612, 10.1038/ncomms3612 Newman, 2015, Robust enumeration of cell subsets from tissue expression profiles, Nature methods, 12, 453, 10.1038/nmeth.3337 Aran, 2017, xCell: digitally portraying the tissue cellular heterogeneity landscape, Genome Biol., 18, 220, 10.1186/s13059-017-1349-1 Castanheira, 2019, Neutrophils and NETs in modulating acute and chronic inflammation, Blood, 133, 2178, 10.1182/blood-2018-11-844530 Delgado-Rizo, 2017, Neutrophil extracellular traps and its implications in inflammation: an overview, Front. Immunol., 8, 81, 10.3389/fimmu.2017.00081 Fang, 2021, The HMGB1-AGER-STING1 pathway mediates the sterile inflammatory response to alkaliptosis, Biochem. Biophys. Res. Commun., 560, 165, 10.1016/j.bbrc.2021.05.003 Fauster, 2019, Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking, Cell Death Differ., 26, 1138, 10.1038/s41418-018-0192-6 Galluzzi, 2017, Necroptosis: mechanisms and relevance to disease, Annu. Rev. Pathol., 12, 103, 10.1146/annurev-pathol-052016-100247 Giampietri, 2014, Necroptosis: molecular signalling and translational implications, Int. J. Cell Biol., 2014, 10.1155/2014/490275 Guicciardi, 2004, Lysosomes in cell death, Oncogene, 23, 2881, 10.1038/sj.onc.1207512 Holze, 2018, Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway, Nat. Immunol., 19, 130, 10.1038/s41590-017-0013-y Kavčič, 2017, Lysosomes in programmed cell death pathways: from initiators to amplifiers, Biol. Chem., 398, 289, 10.1515/hsz-2016-0252 Khan, 2017, Transcriptional firing helps to drive NETosis, Sci. Rep., 7, 41749, 10.1038/srep41749 Levine, 2019, Biological functions of autophagy genes: a disease perspective, Cell, 176, 11, 10.1016/j.cell.2018.09.048 Li, 2021, A novel six-gene-based prognostic model predicts survival and clinical risk score for gastric cancer, Front. Genet., 12 Liu, 2020, Alkaliptosis: a new weapon for cancer therapy, Cancer Gene Ther., 27, 267, 10.1038/s41417-019-0134-6 Martins, 2017, Entosis: the emerging face of non-cell-autonomous type IV programmed death, Biom. J., 40, 133 Robinson, 2019, Programmed necrotic cell death of macrophages: focus on pyroptosis, necroptosis, and parthanatos, Redox Biol., 26, 10.1016/j.redox.2019.101239 Skendros, 2018, Autophagy in neutrophils: from Granulopoiesis to neutrophil extracellular traps, Front. Cell Developm. Biol., 6, 109, 10.3389/fcell.2018.00109 Song, 2018, JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice, Gastroenterology, 154, 1480, 10.1053/j.gastro.2017.12.004 Ye, 2021, A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer, Cell Death Dis., 7, 71, 10.1038/s41420-021-00451-x Hao, 2021, Integrated analysis of multimodal single-cell data, Cell, 184, 3573, 10.1016/j.cell.2021.04.048 Gao, 2021, Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes, Nat. Biotechnol., 39, 599, 10.1038/s41587-020-00795-2 Neftel, 2019, An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma, Cell, 178, 835, 10.1016/j.cell.2019.06.024 Jin, 2021, Inference and analysis of cell-cell communication using CellChat, Nat. Commun., 12, 1088, 10.1038/s41467-021-21246-9 Tibshirani, 1997, The lasso method for variable selection in the cox model, Stat. Med., 16, 385, 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3 Hu, 2019, The dynamic uptake and release of SOD3 from intracellular stores in macrophages modulates the inflammatory response, Redox Biol., 26, 10.1016/j.redox.2019.101268 Zhao, 2022, Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3, Eur. J. Pharmacol., 929, 10.1016/j.ejphar.2022.175115 Martínez-Reyes, 2021, Cancer metabolism: looking forward, Nat. Rev. Cancer, 21, 669, 10.1038/s41568-021-00378-6 Chang, 2021, p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells, Cell. Signal., 77, 10.1016/j.cellsig.2020.109820 Matés, 2020, Glutaminases regulate glutathione and oxidative stress in cancer, Arch. Toxicol., 94, 2603, 10.1007/s00204-020-02838-8 Morotti, 2021, Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer, Br. J. Cancer, 124, 494, 10.1038/s41416-020-01113-y Mukha, 2021, GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy, Theranostics, 11, 7844, 10.7150/thno.58655 Tong, 2021, SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells, Mol. Cell, 81, 2303, 10.1016/j.molcel.2021.04.002 Mohrenz, 2013, Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death, Apoptos. Int. J. Program. Cell Death, 18, 1416, 10.1007/s10495-013-0877-8 Yang, 2009, Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling, Cancer Res., 69, 7986, 10.1158/0008-5472.CAN-09-2266 Goji, 2017, Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation, J. Biol. Chem., 292, 19721, 10.1074/jbc.M117.814392 Rojo, 2004, Regulation of cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB, J. Neurosci., 24, 7324, 10.1523/JNEUROSCI.2111-04.2004 Rapoport, 2020, Role of the Neutrophil in the pathogenesis of advanced cancer and impaired responsiveness to therapy, Molecules (Basel, Switzerland), 25, 10.3390/molecules25071618 Mensurado, 2018, Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress, PLoS Biol., 16, 10.1371/journal.pbio.2004990 Ishimoto, 2014, Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation, Carcinogenesis, 35, 1003, 10.1093/carcin/bgt402 Bauernhofer, 2003, Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer, Eur. J. Immunol., 33, 119, 10.1002/immu.200390014 Tsai, 2021, IL-25 induced ROS-mediated M2 macrophage polarization via AMPK-associated Mitophagy, Int. J. Mol. Sci., 23, 10.3390/ijms23010003 Zhang, 2020, Ketogenic diet elicits antitumor properties through inducing oxidative stress, inhibiting MMP-9 expression, and rebalancing M1/M2 tumor-associated macrophage phenotype in a mouse model of colon cancer, J. Agric. Food Chem., 68, 11182, 10.1021/acs.jafc.0c04041 Che, 2016, Expanding roles of superoxide dismutases in cell regulation and cancer, Drug Discov. Today, 21, 143, 10.1016/j.drudis.2015.10.001 Griess, 2017, Extracellular superoxide dismutase and its role in cancer, Free Radic. Biol. Med., 112, 464, 10.1016/j.freeradbiomed.2017.08.013 Griess, 2020, Association of SOD3 promoter DNA methylation with its down-regulation in breast carcinomas, Epigenetics, 15, 1325, 10.1080/15592294.2020.1777666 Teoh-Fitzgerald, 2012, Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis, Mol. Cancer Res. MCR, 10, 40, 10.1158/1541-7786.MCR-11-0501 Teoh, 2009, Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion, Cancer Res., 69, 6355, 10.1158/0008-5472.CAN-09-1195 Mira, 2018, SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α, Nature comm., 9, 575, 10.1038/s41467-018-03079-1 Zhao, 2012, Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study, BMC cancer, 12, 617, 10.1186/1471-2407-12-617 Laurila, 2009, SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression, PLoS One, 4, 10.1371/journal.pone.0005786 Petersen, 2021, Novel and converging ways of NOX2 and SOD3 in trafficking and redox signaling in macrophages, Antioxidants (Basel, Switzerland), 10 Zhang, 2021, A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening, Cancer Lett., 500, 87, 10.1016/j.canlet.2020.12.013 Nissen, 2022, Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels, Jama, 327, 1679, 10.1001/jama.2022.5050 Luo, 2021, Structure-based pharmacophore modeling, virtual screening, molecular docking, ADMET, and molecular dynamics (MD) simulation of potential inhibitors of PD-L1 from the library of marine natural products, Mar. Drugs, 20, 10.3390/md20010029